Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | NOS3 | P29474 | 1/20 | 0.36 |
| ▸ | NOS1 | P29475 | 1/20 | 0.36 |
| ▸ | NOS2 | P35228 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 17/20 | 0.36 |
| ▸ | CA2 | P00918 | 17/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | KDM6B | O15054 | 1/20 | 0.32 |
| ▸ | KDM5C | P41229 | 1/20 | 0.32 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.32 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.32 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3812152 | 0.94 | NOS3 (0.39) | ALDH1A1NOS3NOS1NOS2CA1 | |
| SCHEMBL21404095 | 0.92 | NOS3 (0.38) | ALDH1A1NOS3NOS1NOS2CA1 | |
| SCHEMBL29175400 | 0.92 | NOS3 (0.38) | ALDH1A1NOS3NOS1NOS2CA1 | |
| Water SCHEMBL21810558 | 0.92 | NOS3 (0.38) | ALDH1A1NOS3NOS1NOS2CA1 | |
| SCHEMBL3817553 | 0.91 | ALDH1A1 (0.54) | ALDH1A1NOS3NOS1NOS2CA1 | |
| SCHEMBL28959584 | 0.90 | NOS3 (0.34) | ALDH1A1NOS3NOS1NOS2CA1 | |
| SCHEMBL1242115 | 0.90 | CA1 (0.34) | ALDH1A1NOS3NOS1NOS2CA1 | |
| SCHEMBL21404061 | 0.88 | CA1 (0.39) | NOS3NOS1NOS2CA1CA2 | |
| SCHEMBL584167 | 0.86 | NOS3 (0.35) | NOS3NOS1NOS2CA1CA2 | |
| SCHEMBL5345186 | 0.86 | CA1 (0.36) | NOS3NOS1NOS2CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3908297-B1 | FIBROBLAST REGENERATIVE CELLS | SPINALCYTE LLC (US) | 2025-10-22 | — | — | EP | claimed |
| US-20220110979-A1 | FIBROBLAST REGENERATIVE CELLS | FIGENE, LLC | 2022-04-14 | — | — | US | claimed |
| EP-3908297-A1 | FIBROBLAST REGENERATIVE CELLS | Figene, LLC (US) | 2021-11-17 | — | — | EP | claimed |
| WO-2020146874-A1 | FIBROBLAST REGENERATIVE CELLS | FIGENE, LLC (US) | 2020-07-16 | — | — | WO | claimed |
| US-9855296-B2 | Methods and compositions for mitochondrial replacement therapy | THE MCLEAN HOSPITAL CORPORATION (US) | 2018-01-02 | — | — | US | claimed |
| US-9603872-B2 | Methods and compositions for mitochondrial replacement therapy | The McLeon Hospital Corporation (US) | 2017-03-28 | — | — | US | claimed |
| US-20170065635-A1 | METHODS AND COMPOSITIONS FOR MITOCHONDRIAL REPLACEMENT THERAPY | THE MCLEAN HOSPITAL CORPORATION | 2017-03-09 | — | — | US | claimed |
| EP-2641617-A1 | Methods and compositions for mitochondrial replacement therapy | THE McLEAN HOSPITAL CORPORATION (US) | 2013-09-25 | — | — | EP | claimed |
| US-20110008310-A1 | METHODS AND COMPOSITIONS FOR MITOCHONDRIAL REPLACEMENT THERAPY | THE MCLEAN HOSPITAL CORPORATION (US) | 2011-01-13 | — | — | US | claimed |
| EP-2150117-A1 | METHODS AND COMPOSITIONS FOR MITOCHONDRIAL REPLACEMENT THERAPY | The McLean Hospital Corporation (US) | 2010-02-10 | — | — | EP | claimed |
| WO-2008137035-A1 | METHODS AND COMPOSITIONS FOR MITOCHONDRIAL REPLACEMENT THERAPY | THE MCLEAN HOSPITAL CORPORATION (US) | 2008-11-13 | — | — | WO | claimed |
| US-7226947-B1 | Use of creatine as a fat substitute | ALZCHEM TROSTBERG GMBH (DE) | 2007-06-05 | — | — | US | claimed |
| CN-1224328-C | Use of creatine as fodder additive | DSM FINE CHEM AUSTRIA GMBH (AT) | 2005-10-26 | — | — | CN | claimed |
| EP-1176875-B1 | USE OF CREATINE AS A FEED SUBSTITUTE | DSM FINE CHEM AUSTRIA GMBH (AT) | 2005-01-19 | — | — | EP | claimed |
| CN-1350434-A | Use of creatine as fodder additive | DSM FINE CHEMICALS AUSTRIA (AT) | 2002-05-22 | — | — | CN | claimed |
| EP-3908297-B1 | FIBROBLAST REGENERATIVE CELLS | SPINALCYTE LLC (US) | 2025-10-22 | — | — | EP | disclosed |
| US-20240238337-A1 | COMPOSITIONS OF FUNCTIONAL MITOCHONDRIA AND USES THEREOF | MINOVIA THERAPEUTICS LTD. (IL) | 2024-07-18 | — | — | US | disclosed |
| US-7226947-B1 | Use of creatine as a fat substitute | ALZCHEM TROSTBERG GMBH (DE) | 2007-06-05 | — | — | US | disclosed |
| CN-1224328-C | Use of creatine as fodder additive | DSM FINE CHEM AUSTRIA GMBH (AT) | 2005-10-26 | — | — | CN | disclosed |
| CN-1350434-A | Use of creatine as fodder additive | DSM FINE CHEMICALS AUSTRIA (AT) | 2002-05-22 | — | — | CN | disclosed |